Home - Products - Others - Other Targets - 3-Angeloyloxy-4-senecioyloxy-2,3-dihydrooroselol

3-Angeloyloxy-4-senecioyloxy-2,3-dihydrooroselol

CAS No. 1221686-60-7

3-Angeloyloxy-4-senecioyloxy-2,3-dihydrooroselol( —— )

Catalog No. M31849 CAS No. 1221686-60-7

3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 783 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Angeloyloxy-4-senecioyloxy-2,3-dihydrooroselol
  • Note
    Research use only, not for human use.
  • Brief Description
    3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol is a natural product for research related to life sciences.
  • Description
    3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1221686-60-7
  • Formula Weight
    426.5
  • Molecular Formula
    C24H26O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3beta-Androstanediol

    3beta-Androstanediol is an endogenous estrogen.?

  • Neoanhydropodophyllo...

    Neoanhydropodophyllol is a cyclolignan derivative, with antineoplastic activity. Neoanhydropodophyllol displays cytotoxicity against several cancer cells (leukemia, lung carcinoma and colon carcinoma).

  • Linoleic Acid Amide

    Linoleic acid amide is a primary fatty acid amide derived from linoleic acid . It is reported to regulate Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (IC50 = 15-53 µM).